This notice is for prior information only
Legal Basis:
Directive 2014/24/EU
Section I: Contracting authority
I.1)Name and addresses
Official name: SERVICIO MADRILEÑO DE SALUD - HOSPITAL UNIVERSITARIO 12 DE OCTUBRE
National registration number: Q2877010E
Postal address: AVENIDA DE CORDOBA, SIN NÚMERO
Town: MADRID
NUTS code:
ES300 Madrid
Postal code: 28041
Country: Spain
E-mail:
ucontratacion.hdoc@salud.madrid.org
Telephone: +34 913908552
Fax: +34 913908181
Internet address(es):
Main address:
http://www.madrid.org/contratospublicos
I.3)Communication
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 765 964.74 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS GLAXOSMITHKLINE S.A.: BELANTAMAB MAFODOTINA 100 MG VIAL
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ALEXION PHARMA SPAIN: ravulizumab 100 mg/ml inyectable perfusión 11 ml
II.1.2)Main CPV code
33652300 Immunosuppressive agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ALEXION PHARMA SPAIN: ravulizumab 100 mg/ml inyectable perfusión 11 ml
II.1.5)Estimated total value
Value excluding VAT: 5 291 098.61 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ALEXION PHARMA SPAIN: ravulizumab 100 mg/ml inyectable perfusión 11 ml
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ALEXION PHARMA SPAIN: ravulizumab 100 mg/ml inyectable perfusión 3 ml
II.1.2)Main CPV code
33652300 Immunosuppressive agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ALEXION PHARMA SPAIN: ravulizumab 100 mg/ml inyectable perfusión 3 ml
II.1.5)Estimated total value
Value excluding VAT: 6 012 602.21 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ALEXION PHARMA SPAIN: ravulizumab 100 mg/ml inyectable perfusión 3 ml
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33651100 Antibacterials for systemic use
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 619 269.59 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS SANOFI AVENTIS, S.A.: ALEMTUZUMAB 10 MG/ML INYECTABLE PERFUSIÓN 1,2 ML
II.1.2)Main CPV code
33652300 Immunosuppressive agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS SANOFI AVENTIS, S.A.: ALEMTUZUMAB 10 MG/ML INYECTABLE PERFUSIÓN 1,2 ML
II.1.5)Estimated total value
Value excluding VAT: 697 450.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS SANOFI AVENTIS, S.A.: ALEMTUZUMAB 10 MG/ML INYECTABLE PERFUSIÓN 1,2 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ADVANCED ACCELERATOR APPLICATI: LUTECIO (177LU) OXODOTREOTIDA 370 MBQ/ML INYECTABLE PERFUSIÓN 25 ML
II.1.2)Main CPV code
33696000 Reagents and contrast media
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ADVANCED ACCELERATOR APPLICATI: LUTECIO (177LU) OXODOTREOTIDA 370 MBQ/ML INYECTABLE PERFUSIÓN 25 ML
II.1.5)Estimated total value
Value excluding VAT: 3 032 640.00 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ADVANCED ACCELERATOR APPLICATI: LUTECIO (177LU) OXODOTREOTIDA 370 MBQ/ML INYECTABLE PERFUSIÓN 25 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS SANOFI AVENTIS, S.A.: CAPLACIZUMAB 10 MG INYECTABLE
II.1.2)Main CPV code
33621100 Antithrombotic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS SANOFI AVENTIS, S.A.: CAPLACIZUMAB 10 MG INYECTABLE
II.1.5)Estimated total value
Value excluding VAT: 1 615 719.46 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS SANOFI AVENTIS, S.A.: CAPLACIZUMAB 10 MG INYECTABLE
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS SANOFI AVENTIS, S.A.: CEMIPLIMAB 350 MG INYECTABLE PERFUSION
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS SANOFI AVENTIS, S.A.: CEMIPLIMAB 350 MG INYECTABLE PERFUSION
II.1.5)Estimated total value
Value excluding VAT: 437 851.90 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS SANOFI AVENTIS, S.A.: CEMIPLIMAB 350 MG INYECTABLE PERFUSION
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS ALNYLAM PHARMACEUTICALS SPAIN, S. L.: GIVOSIRAN 189 MG/ML INYECTABLE 1 ML
II.1.2)Main CPV code
33610000 Medicinal products for the alimentary tract and metabolism
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS ALNYLAM PHARMACEUTICALS SPAIN, S. L.: GIVOSIRAN 189 MG/ML INYECTABLE 1 ML
II.1.5)Estimated total value
Value excluding VAT: 3 217 496.26 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS ALNYLAM PHARMACEUTICALS SPAIN, S. L.: GIVOSIRAN 189 MG/ML INYECTABLE 1 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS SANOFI AVENTIS, S.A.: ISATUXIMAB 20 MG/ML INYECTABLE PERFUSIÓN 5 ML
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS SANOFI AVENTIS, S.A.: ISATUXIMAB 20 MG/ML INYECTABLE PERFUSIÓN 5 ML
II.1.5)Estimated total value
Value excluding VAT: 861 163.16 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS SANOFI AVENTIS, S.A.: ISATUXIMAB 20 MG/ML INYECTABLE PERFUSIÓN 5 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33670000 Medicinal products for the respiratory system
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 789 359.87 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS VIFOR PHARMA ESPAÑA, S.L.: HIERRO CARBOXIMALTOSA 50 MG/ML INYECTABLE 20 ML
II.1.2)Main CPV code
33621300 Antianaemic preparations
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS VIFOR PHARMA ESPAÑA, S.L.: HIERRO CARBOXIMALTOSA 50 MG/ML INYECTABLE 20 ML
II.1.5)Estimated total value
Value excluding VAT: 2 790 227.37 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS VIFOR PHARMA ESPAÑA, S.L.: HIERRO CARBOXIMALTOSA 50 MG/ML INYECTABLE 20 ML
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33652300 Immunosuppressive agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 545 578.23 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS CHIESI ESPAÑA, S.A.: MERCAPTAMINA 75 MG CÁPSULA
II.1.2)Main CPV code
33610000 Medicinal products for the alimentary tract and metabolism
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS CHIESI ESPAÑA, S.A.: MERCAPTAMINA 75 MG CÁPSULA
II.1.5)Estimated total value
Value excluding VAT: 2 281 589.70 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS CHIESI ESPAÑA, S.A.: MERCAPTAMINA 75 MG CÁPSULA
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS KYOWA KIRIN FARMACÉUTICA S.L.U: MOGAMULIZUMAB 20 MG VIAL
II.1.2)Main CPV code
33652100 Antineoplastic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS KYOWA KIRIN FARMACÉUTICA S.L.U: MOGAMULIZUMAB 20 MG VIAL
II.1.5)Estimated total value
Value excluding VAT: 2 526 750.72 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS KYOWA KIRIN FARMACÉUTICA S.L.U: MOGAMULIZUMAB 20 MG VIAL
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
EXCLUSIVOS BIOGEN SPAIN, S.L.U.: NATALIZUMAB 150 MG INYECTABLE 1ML JERINGA PRECARGADA
II.1.2)Main CPV code
33652300 Immunosuppressive agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
EXCLUSIVOS BIOGEN SPAIN, S.L.U.: NATALIZUMAB 150 MG INYECTABLE 1ML JERINGA PRECARGADA
II.1.5)Estimated total value
Value excluding VAT: 2 376 658.52 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
EXCLUSIVOS BIOGEN SPAIN, S.L.U.: NATALIZUMAB 150 MG INYECTABLE 1ML JERINGA PRECARGADA
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33621100 Antithrombotic agents
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 787 619.56 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
II.2.14)Additional information
II.3)Estimated date of publication of contract notice:
31/03/2023
Section II: Object
II.1)Scope of the procurement
II.1.2)Main CPV code
33632200 Muscle relaxants
II.1.3)Type of contract
Supplies
II.1.4)Short description:
II.1.5)Estimated total value
Value excluding VAT: 444 812.07 EUR
II.1.6)Information about lots
This contract is divided into lots: no
II.2)Description
II.2.3)Place of performance
NUTS code: ES30 Comunidad de Madrid
II.2.4)Description of the procurement:
II.2.14)